Mylan (NASDAQ: MYL) has restarted production of its hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility as a potential treatment for COVID-19, the disease caused by the new …
More Mylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 Treatment Videos